TY - JOUR
T1 - Torsades de pointes, a potential complication of diuretic-induced hypokalemia and hypomagnesemia in patients with congestive heart failure
T2 - Conference presentation of a generic patient
AU - Cohen, Jerome D.
AU - Blumenthal, Roger
AU - Horn, Howard R.
AU - Weintraub, Howard
AU - Weglicki, William
N1 - Funding Information:
This research was supported by an unrestricted educational grant from Well-Spring Pharmaceutical Corporation, Neptune, New Jersey.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2002/12/1
Y1 - 2002/12/1
N2 - Background: Despite improvements in care, the prognosis for patients with congestive heart failure (CHF) remains poor. Fifty percent of patients with CHF suffer from arrhythmia and sudden cardiac death. This may be attributable in part to the use of medications that contribute to electrolyte imbalance. Objective: This article presents a case report of a woman with CHF due to left ventricular systolic dysfunction. Results: The case report involved a 52-year-old white woman with a history of paroxysmal atrial fibrillation, atypical chest pain, and dyslipidemia. Her medical treatment had included the use of furosemide (a loop diuretic), digoxin, and sotalol; she subsequently developed torsades de pointes (TdP). An electrocardiogram showed normal sinus rhythm; the QTc interval was 530 msec. Levels of digoxin, K+, and Mg2+ were 1.8 ng/mL, 3.5 mEq/L, and 1.5 mEq/L, respectively. Results of a Holter monitor recording suggested that the hypomagnesemia and hypokalemia, interacting with the digoxin and sotalol, potentiated the development of a prolonged QT interval. To ensure the TdP did not recur, an IV bolus of Mg2+ was administered and oral triamterene therapy was added to the patient's current medications. These additions appeared to correct the electrolyte imbalance. Conclusion: This case exemplifies the importance of recognizing and managing electrolyte imbalance in the treatment of patients with CHF.
AB - Background: Despite improvements in care, the prognosis for patients with congestive heart failure (CHF) remains poor. Fifty percent of patients with CHF suffer from arrhythmia and sudden cardiac death. This may be attributable in part to the use of medications that contribute to electrolyte imbalance. Objective: This article presents a case report of a woman with CHF due to left ventricular systolic dysfunction. Results: The case report involved a 52-year-old white woman with a history of paroxysmal atrial fibrillation, atypical chest pain, and dyslipidemia. Her medical treatment had included the use of furosemide (a loop diuretic), digoxin, and sotalol; she subsequently developed torsades de pointes (TdP). An electrocardiogram showed normal sinus rhythm; the QTc interval was 530 msec. Levels of digoxin, K+, and Mg2+ were 1.8 ng/mL, 3.5 mEq/L, and 1.5 mEq/L, respectively. Results of a Holter monitor recording suggested that the hypomagnesemia and hypokalemia, interacting with the digoxin and sotalol, potentiated the development of a prolonged QT interval. To ensure the TdP did not recur, an IV bolus of Mg2+ was administered and oral triamterene therapy was added to the patient's current medications. These additions appeared to correct the electrolyte imbalance. Conclusion: This case exemplifies the importance of recognizing and managing electrolyte imbalance in the treatment of patients with CHF.
KW - Congestive heart failure
KW - Diuretics
KW - Hypokalemia
KW - Hypomagnesemia
KW - Torsades de pointes
UR - http://www.scopus.com/inward/record.url?scp=0036942895&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036942895&partnerID=8YFLogxK
U2 - 10.1016/S0011-393X(02)80084-4
DO - 10.1016/S0011-393X(02)80084-4
M3 - Article
AN - SCOPUS:0036942895
SN - 0011-393X
VL - 63
SP - 803
EP - 809
JO - Current Therapeutic Research
JF - Current Therapeutic Research
IS - 12
ER -